Yuki Oya
Last active: 10/27/2015

Profile

None provided

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Living donor liver transplantation from a heterozygous parent for classical maple syrup urine disease. Kadohisa M, Matsumoto S, Sawada H, Honda M, Murokawa T, Hayashida S, Ohya Y, Lee KJ, Yamamoto H, Mitsubuchi H, Endo F, Inomata Y (2015) Pediatr Transplant 19(3): E66-9
    › Primary publication · 25708273 (PubMed)
  2. Specific activin receptor-like kinase 3 inhibitors enhance liver regeneration. Tsugawa D, Oya Y, Masuzaki R, Ray K, Engers DW, Dib M, Do N, Kuramitsu K, Ho K, Frist A, Yu PB, Bloch KD, Lindsley CW, Hopkins CR, Hong CC, Karp SJ (2014) J Pharmacol Exp Ther 351(3): 549-58
    › Primary publication · 25271257 (PubMed) · PMC4244585 (PubMed Central)
  3. Generation of familial amyloidotic polyneuropathy-specific induced pluripotent stem cells. Isono K, Jono H, Ohya Y, Shiraki N, Yamazoe T, Sugasaki A, Era T, Fusaki N, Tasaki M, Ueda M, Shinriki S, Inomata Y, Kume S, Ando Y (2014) Stem Cell Res 12(2): 574-83
    › Primary publication · 24531302 (PubMed)
  4. Single-center experience and long-term outcomes of duct-to-duct biliary reconstruction in infantile living donor liver transplantation. Yamamoto H, Hayashida S, Asonuma K, Honda M, Suda H, Murokawa T, Ohya Y, Lee KJ, Takeichi T, Inomata Y (2014) Liver Transpl 20(3): 347-54
    › Primary publication · 24415519 (PubMed)
  5. False tacrolimus concentrations measured by antibody-conjugated magnetic immunoassay in liver transplant patient: 2 case reports and literature review. Taguchi K, Ohmura T, Ohya Y, Horio M, Furukawa K, Jono H, Inomata Y, Saito H (2014) Exp Clin Transplant 12(5): 474-8
    › Primary publication · 24206050 (PubMed)
  6. Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation. Oshima T, Kawahara S, Ueda M, Kawakami Y, Tanaka R, Okazaki T, Misumi Y, Obayashi K, Yamashita T, Ohya Y, Ihse E, Shinriki S, Tasaki M, Jono H, Asonuma K, Inomata Y, Westermark P, Ando Y (2014) J Neurol Neurosurg Psychiatry 85(7): 740-6
    › Primary publication · 24023270 (PubMed)
  7. Re-evaluation of the indications for liver transplantation in Wilson's disease based on the outcomes of patients referred to a transplant center. Ohya Y, Okajima H, Honda M, Hayashida S, Suda H, Matsumoto S, Lee KJ, Yamamoto H, Takeichi T, Mitsubuchi H, Asonuma K, Endo F, Inomata Y (2013) Pediatr Transplant 17(4): 369-73
    › Primary publication · 23692600 (PubMed)
  8. Incidence and risk factors for new-onset diabetes in living-donor liver transplant recipients. Honda M, Asonuma K, Hayashida S, Suda H, Ohya Y, Lee KJ, Yamamoto H, Takeichi T, Inomata Y (2013) Clin Transplant 27(3): 426-35
    › Primary publication · 23464510 (PubMed)
  9. Peritransplant gastrointestinal symptoms in familial amyloidotic polyneuropathy. Ohya Y, Isono K, Obayashi K, Hayashida S, Lee KJ, Yamamoto H, Takeichi T, Asonuma K, Ando Y, Inomata Y (2013) Exp Clin Transplant 11(4): 327-31
    › Primary publication · 23432183 (PubMed)
  10. UW solution improved with high anti-apoptotic activity by S-nitrosated human serum albumin. Ishima Y, Shinagawa T, Yoneshige S, Kragh-Hansen U, Ohya Y, Inomata Y, Kai T, Otagiri M, Maruyama T (2013) Nitric Oxide : 36-42
    › Primary publication · 23402724 (PubMed)
  11. Liver transplant from an ABO-incompatible and hepatitis C antibody-positive but an HCV-RNA negative living donor in a familial amyloid polyneuropathy patient. Takeichi T, Asonuma K, Yamamoto H, Ohya Y, Okumura K, Lee KJ, Inomata Y (2013) Exp Clin Transplant 11(2): 182-5
    › Primary publication · 23194392 (PubMed)
  12. Pathological changes long after liver transplantation in a familial amyloidotic polyneuropathy patient. Obayashi K, Ueda M, Oshima T, Kawahara S, Misumi Y, Yamashita T, Jono H, Yazaki M, Kametani F, Ikeda S, Ohya Y, Asonuma K, Inomata Y, Ando Y (2012) BMJ Case Rep
    › Primary publication · 22907857 (PubMed) · PMC4543899 (PubMed Central)
  13. Current state of domino transplantation in Japan in terms of surgical procedures and de novo amyloid neuropathy. Asonuma K, Ohya Y, Isono K, Takeichi T, Yamamoto H, Lee KJ, Okumura K, Ando Y, Inomata Y (2012) Amyloid : 75-7
    › Primary publication · 22620971 (PubMed)
  14. A thoracoabdominal approach in revision of the hepatic hilum after left lobe living donor liver transplantation. Honda M, Takeichi T, Ohya Y, Okumura K, Lee KJ, Yamamoto H, Asonuma K, Inomata Y (2012) J Pediatr Surg 47(3): e13-6
    › Primary publication · 22424370 (PubMed)
  15. Manifestations of transthyretin-related familial amyloidotic polyneuropathy: long-term follow-up of Japanese patients after liver transplantation. Ohya Y, Okamoto S, Tasaki M, Ueda M, Jono H, Obayashi K, Takeda K, Okajima H, Asonuma K, Hara R, Tanihara H, Ando Y, Inomata Y (2011) Surg Today 41(9): 1211-8
    › Primary publication · 21874417 (PubMed)
  16. Amyloid turnover after liver transplantation in FAP. Obayashi K, Ueda M, Jono H, Yamashita T, Yazaki M, Kametani F, Ohya Y, Inomata Y, Ikeda S, Ando Y (2011) Amyloid : 187-9
    › Primary publication · 21838482 (PubMed)
  17. Factors predicting persistent thrombocytopenia after living donor liver transplantation in pediatric patients. Honda M, Yamamoto H, Hayashida S, Suda H, Ohya Y, Lee KJ, Takeichi T, Asonuma K, Inomata Y (2011) Pediatr Transplant 15(6): 601-5
    › Primary publication · 21790916 (PubMed)
  18. Development of hepatic angiomyolipoma accompanied with focal nodular hyperplasia long after treatment of pelvic rhabdomyosarcoma. Honda M, Lee KJ, Hashimoto S, Hayashida S, Suda H, Ohya Y, Yamamoto H, Takeichi T, Asonuma K, Inomata Y (2011) J Pediatr Surg 46(6): 1267-70
    › Primary publication · 21683235 (PubMed)
  19. Amyloid neuropathy in a younger domino liver transplanted recipient. Obayashi K, Yamashita T, Tasaki M, Ueda M, Shono M, Jono H, Ohshima T, Ohya Y, Asonuma K, Inomata Y, Ando Y (2011) Muscle Nerve 43(3): 449-50
    › Primary publication · 21319169 (PubMed)
  20. Effect of recipient-derived cells on the progression of familial amyloidotic polyneuropathy after liver transplantation: a retrospective study. Ohya Y, Jono H, Nakamura M, Hayashida S, Ueda M, Obayashi K, Misumi S, Asonuma K, Ando Y, Inomata Y (2010) Ann Clin Biochem 47(Pt 6): 529-34
    › Primary publication · 20930032 (PubMed)
  21. Difficulty in sustaining hepatic outflow in left lobe but not right lobe living donor liver transplantation. Shirouzu Y, Ohya Y, Hayashida S, Asonuma K, Inomata Y (2011) Clin Transplant 25(4): 625-32
    › Primary publication · 20718823 (PubMed)
  22. Reduction of left-lateral segment from living donors for liver transplantation in infants weighing less than 7 kg: technical aspects and outcome. Shirouzu Y, Ohya Y, Hayashida S, Yoshii T, Asonuma K, Inomata Y (2010) Pediatr Transplant 14(6): 709-14
    › Primary publication · 20477975 (PubMed)
  23. Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients. Hara R, Kawaji T, Ando E, Ohya Y, Ando Y, Tanihara H (2010) Arch Ophthalmol 128(2): 206-10
    › Primary publication · 20142544 (PubMed)
  24. Massive ascites after living donor liver transplantation with a right lobe graft larger than 0.8% of the recipient's body weight. Shirouzu Y, Ohya Y, Suda H, Asonuma K, Inomata Y (2010) Clin Transplant 24(4): 520-7
    › Primary publication · 19843111 (PubMed)
  25. How to handle a huge portosystemic shunt in adult living donor liver transplantation with a small-for-size graft: report of a case. Shirouzu Y, Ohya Y, Tsukamoto Y, Yamamoto H, Lee KJ, Okajima H, Asonuma K, Inomata Y (2009) Surg Today 39(7): 637-40
    › Primary publication · 19562457 (PubMed)
  26. Management of undifferentiated sarcoma of the liver including living donor liver transplantation as a backup procedure. Okajima H, Ohya Y, Lee KJ, Yamamoto H, Asonuma K, Nagaoki Y, Ohama K, Korogi M, Anan T, Hashiyama M, Endo F, Iyama K, Inomata Y (2009) J Pediatr Surg 44(2): e33-8
    › Primary publication · 19231519 (PubMed)
  27. Revisited impact of recipient age on the outcome of living donor liver transplantation for biliary atresia in the recent "transplantation era" in Japan. Ohya Y, Okajima H, Nishimori A, Lee KJ, Shirouzu Y, Yamamoto H, Takeichi T, Asonuma K, Inomata Y (2009) Pediatr Transplant 13(7): 868-72
    › Primary publication · 19207224 (PubMed)
  28. Biliary reconstruction for infantile living donor liver transplantation: Roux-en-Y hepaticojejunostomy or duct-to-duct choledochocholedochostomy? Shirouzu Y, Okajima H, Ogata S, Ohya Y, Tsukamoto Y, Yamamoto H, Takeichi T, Kwang-Jong L, Asonuma K, Inomata Y (2008) Liver Transpl 14(12): 1761-5
    › Primary publication · 19025922 (PubMed)
  29. Duct-to-duct biliary reconstruction in pediatric living donor liver transplantation. Okajima H, Inomata Y, Asonuma K, Ueno M, Ishiko T, Takeichi T, Kodera A, Yoshimoto K, Ohya Y (2005) Pediatr Transplant 9(4): 531-3
    › Primary publication · 16048608 (PubMed)